.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires introduction of people with MASLD as well as dimension of liver results in cardio-- renal-- metabolic trials, when records recommend mechanistically tenable benefits and scientific protection-- and describes factors for trial concept as well as regulatory approval.